1,833 Shares in Corteva, Inc. (NYSE:CTVA) Acquired by Register Financial Advisors LLC

Register Financial Advisors LLC acquired a new position in shares of Corteva, Inc. (NYSE:CTVAFree Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 1,833 shares of the company’s stock, valued at approximately $106,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of CTVA. Artemis Investment Management LLP bought a new position in Corteva during the 1st quarter worth $63,238,000. Cardinal Capital Management raised its position in shares of Corteva by 5.6% during the first quarter. Cardinal Capital Management now owns 25,326 shares of the company’s stock worth $1,461,000 after purchasing an additional 1,349 shares during the period. Janiczek Wealth Management LLC increased its position in Corteva by 27.1% in the 1st quarter. Janiczek Wealth Management LLC now owns 2,252 shares of the company’s stock worth $130,000 after purchasing an additional 480 shares during the last quarter. Wealthcare Advisory Partners LLC increased its position in Corteva by 20.0% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 6,435 shares of the company’s stock worth $371,000 after purchasing an additional 1,074 shares during the last quarter. Finally, GoalVest Advisory LLC acquired a new position in Corteva in the 1st quarter worth about $49,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, insider Brian Titus sold 12,134 shares of the firm’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $56.65, for a total value of $687,391.10. Following the sale, the insider now owns 13,495 shares in the company, valued at $764,491.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Corteva news, SVP Cornel B. Fuerer sold 39,736 shares of Corteva stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $57.41, for a total value of $2,281,243.76. Following the completion of the transaction, the senior vice president now directly owns 126,628 shares of the company’s stock, valued at approximately $7,269,713.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Brian Titus sold 12,134 shares of Corteva stock in a transaction on Monday, May 6th. The stock was sold at an average price of $56.65, for a total transaction of $687,391.10. Following the completion of the transaction, the insider now directly owns 13,495 shares of the company’s stock, valued at $764,491.75. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 83,556 shares of company stock worth $4,795,016. 0.14% of the stock is currently owned by company insiders.

Corteva Stock Up 0.5 %

CTVA stock traded up $0.29 during mid-day trading on Friday, reaching $53.94. 5,954,364 shares of the company traded hands, compared to its average volume of 3,589,447. The stock has a market cap of $37.60 billion, a price-to-earnings ratio of 68.28, a P/E/G ratio of 1.43 and a beta of 0.78. The company has a quick ratio of 0.97, a current ratio of 1.51 and a debt-to-equity ratio of 0.10. Corteva, Inc. has a fifty-two week low of $43.22 and a fifty-two week high of $58.76. The firm’s 50 day moving average price is $54.77 and its 200 day moving average price is $52.73.

Corteva (NYSE:CTVAGet Free Report) last issued its earnings results on Wednesday, May 1st. The company reported $0.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.79 by $0.10. The business had revenue of $4.49 billion for the quarter, compared to analysts’ expectations of $4.65 billion. Corteva had a net margin of 3.32% and a return on equity of 6.68%. The business’s revenue for the quarter was down 8.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.16 EPS. As a group, equities research analysts predict that Corteva, Inc. will post 2.8 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 18th. Shareholders of record on Tuesday, June 4th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date was Tuesday, June 4th. Corteva’s dividend payout ratio (DPR) is presently 81.01%.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on CTVA. Wolfe Research began coverage on Corteva in a research note on Friday, March 1st. They set an “outperform” rating and a $67.00 target price for the company. KeyCorp raised their price target on Corteva from $63.00 to $66.00 and gave the company an “overweight” rating in a report on Tuesday, April 9th. Mizuho dropped their price target on Corteva from $61.00 to $60.00 and set a “buy” rating for the company in a report on Tuesday, June 18th. Royal Bank of Canada increased their price objective on Corteva from $62.00 to $64.00 and gave the company an “outperform” rating in a research report on Monday, May 6th. Finally, JPMorgan Chase & Co. restated a “neutral” rating and issued a $57.00 price target (down from $58.00) on shares of Corteva in a research report on Friday, April 12th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and a consensus target price of $63.00.

Check Out Our Latest Stock Analysis on Corteva

Corteva Company Profile

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Recommended Stories

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.